# Preventing Acute Kidney Injury (AKI) in Pediatric Patients

> **NCT03897335** · PHASE3 · UNKNOWN · sponsor: **Le Bonheur Children's Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Aminophylline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03897335
- **Lead sponsor:** Le Bonheur Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-07
- **Primary completion:** 2023-02-01
- **Final completion:** 2024-02-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03897335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03897335, "Preventing Acute Kidney Injury (AKI) in Pediatric Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03897335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*